Enterprise Value
$222.35 M
+$5.66 M+2.61%
5 min ago
Summary:
Karyopharm Therapeutics enterprise value is currently $222.35 million, with a rise of +$5.66 million (+2.61%) during the most recent trading day. Over the past year, it has dropped by -$770.00 thousand (-0.35%). KPTI enterprise value is now -87.75% below its all-time high of $1.82 billion.KPTI Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KPTI Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +2.6% | +6.0% | +6.0% |
| 1 m1 month | +2.6% | +6.0% | +6.0% |
| 3 m3 months | -4.5% | -9.5% | -9.5% |
| 6 m6 months | +5.3% | +0.6% | +0.0% |
| ytdytd | +7.6% | +18.4% | +18.4% |
| 1 y1 year | -0.3% | +2.6% | -5.9% |
| 5 y5 years | -81.5% | -91.6% | -95.6% |
KPTI Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $227 M | -2.0% | $200 M | +11.0% |
| 3 m | 3 months | $249 M | -10.8% | $200 M | +11.0% |
| 6 m | 6 months | $249 M | -10.8% | $197 M | +12.9% |
| 1 y | 1 year | $331 M | -32.8% | $197 M | +12.9% |
| 3 y | 3 years | $1.08 B | -79.4% | $197 M | +12.9% |
| 5 y | 5 years | $1.82 B | -87.8% | $197 M | +12.9% |
| alltime | all time | $1.82 B | -87.8% | $133 M | +67.4% |
Karyopharm Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $222.35 M(+7.6%) |
| 2024 | $206.65 M(-7.1%) |
| 2023 | $222.49 M(-48.4%) |
| 2022 | $431.07 M(-9.7%) |
| 2021 | $477.17 M(-59.9%) |
| 2020 | $1.19 B(-4.8%) |
| Date | Value |
|---|---|
| 2019 | $1.25 B(+125.2%) |
| 2018 | $554.61 M(+36.4%) |
| 2017 | $406.52 M(+18.1%) |
| 2016 | $344.08 M(-17.5%) |
| 2015 | $416.85 M(-61.2%) |
| 2014 | $1.07 B(+105.6%) |
| 2013 | $522.17 M |
FAQ
- What is Karyopharm Therapeutics enterprise value?
- What is the all time high enterprise value for Karyopharm Therapeutics?
- What is KPTI enterprise value year-to-date change?
- What is Karyopharm Therapeutics enterprise value year-on-year change?
What is Karyopharm Therapeutics enterprise value?
The current enterprise value of KPTI is $222.35 M
What is the all time high enterprise value for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high enterprise value is $1.82 B
What is KPTI enterprise value year-to-date change?
Karyopharm Therapeutics enterprise value has changed by +$15.70 M (+7.60%) since the beginning of the year
What is Karyopharm Therapeutics enterprise value year-on-year change?
Over the past year, KPTI enterprise value has changed by -$770.00 K (-0.35%)